Neuroblastoma Therapeutic Market is driven by Immunotherapy...

adicionou um novo artigo Health

2025-05-21 10:29:53 -

Neuroblastoma Therapeutic Market is driven by Immunotherapy Advancements

The Neuroblastoma Therapeutic Market comprises a diverse portfolio of products including monoclonal antibodies, small-molecule inhibitors, cell-based therapies, vaccines, and combination regimens designed specifically for pediatric oncology. These therapeutics offer targeted action against GD2 and ALK mutations, reducing off-target effects and improving survival rates in high-risk neuroblastoma...

0 Comentários 0 Compartilhamentos 243 Visualizações 0 Anterior